PlatformPlatform overviewCOA reviewSupplier qualificationSupplier follow-up (Vera)Mock inspections (Cato)Patient traceabilityRelease workflowsChain of custodySupplier document collectionAPIPricing
SolutionsCompounding pharmacies503B outsourcing facilitiesClinicsMed spasTelehealth platformsConsultantsSolutions overview
ResourcesMethodologyOrder-level COA traceabilitySupplier packet diligenceResource libraryPublic toolsIntelligenceTrust Center
CompanyAbout VerituraWhy independentPartnersFor counselContact
Log inBook a demo

Valid certificate: The law says valid. This is what a valid COA carries.

Every element a valid certificate of analysis carries, each with the source it rests on, for supplier qualification and every COA review. Free to reuse under CC BY 4.0.

What a valid certificate of analysis carries, from the sources that say so.

Both compounding statutes require a valid certificate of analysis for every bulk drug substance, and neither says what valid means. FDA's guidance, ICH Q7, the WHO model certificate and California's sterile rule each fill in part of it. This standard puts those parts in one list, each element with the source it rests on, so a pharmacy, a supplier or a board can evaluate a COA the same way.

Standard VTR-COA-20261021, version 1, published October 21, 2026. Veritura's published reading, not a rule of FDA, a board or USP. Free to reuse under CC BY 4.0.

The law asks for one. It never says what makes it valid.

Two statutes, one FDA policy and one state rule. Each requires the certificate; only California lists what is on it.

SourceIts wordsApplies to
21 U.S.C. 353a(b)(1)(A)(iii)Bulk drug substances "that are accompanied by valid certificates of analysis for each bulk drug substance".A 503A pharmacy
21 U.S.C. 353b(a)(2)(D)"the bulk drug substances are each accompanied by a valid certificate of analysis."A 503B outsourcing facility
FDA interim policy, 503A (January 2025)The bulk drug substance "must be accompanied by a valid certificate of analysis (COA)" (p. 3); and "Original manufacturer means the entity that originally produced the bulk drug substance and not a subsequent packer, repacker, labeler, or distributor" (p. 13).FDA's reading for 503A; its 503B policy says the same
16 CCR 1736.9(d), CaliforniaA certificate "that includes the compendial name, the grade of the material, and the applicable compendial designations" must be received and evaluated before use, and one from a supplier "must provide the name and address of the manufacturer".Sterile compounding in California

The statutes name the certificate as one of three conditions on a bulk substance: it meets the monograph where one exists, its maker is registered with FDA, and it comes with a valid certificate. The elements below are what the rest of the sources add to the word valid.

Waiting or not run on the read of certificate COA-AS-1180 for ascorbic acid: signed for the quality unit needs a decision, because no line shows it signed or released by a named person for the quality unit; its dates, the manufacturer's telephone and the distributor's reference to the original certificate need decisions too, each with what clears it; the results against the USP monograph await sign-off
Valid, made checkable: what the COA says, the words that require more, and what would pass it.

23 elements, five groups. Each with the source it rests on.

Read top to bottom, this is a certificate's own content first, then what has to be checked outside it.

ElementHow a certificate shows itWhere it comes from
The lot and the substance 5 elements
One certificate for this lotTitled a certificate of analysis, and printing the lot number that is on the container and the receiving record.21 U.S.C. 353a(b)(1)(A)(iii), 353b(a)(2)(D); ICH Q7 11.40
The substance named exactlyThe name with its salt and form, for example "Naltrexone Hydrochloride USP", so the 503A and 503B lists can be read for it.ICH Q7 11.41; WHO model certificate
A grade fit for a drugA pharmacopoeial or pharmaceutical grade, and never a food, technical or dietary supplement grade, or a statement such as "not for human use" or "research use only".ICH Q7 11.41; FDA notice of August 27, 2026; 16 CCR 1736.9(d) and (e)
The batch number, and the maker's own on a reissued certificateThe lot number; on a distributor's certificate, the original manufacturer's batch number as well.ICH Q7 11.41 and 17.61; WHO model certificate
A certificate numberAn identification number for the certificate itself.WHO model certificate
Dates and pages 4 elements
A date of releaseThe release date, or the date beside the signature.ICH Q7 11.41 and 11.43
An expiry or retest dateAn expiry date, or a retest date where the substance carries one.ICH Q7 11.41; FDA draft 503B CGMP guidance (2020)
A date of manufacture, where knownThe date of manufacture; on a repacked lot, both the original date and the repack date, in a possible order.WHO model certificate; IPEC certificate guide (paraphrased)
Every pageEach page numbered with the total, for example "Page 1 of 2", and every numbered page in the file.WHO model certificate; IPEC certificate guide (paraphrased)
Who made it, tested it and signed it 5 elements
The original manufacturer namedThe firm that made the final purified substance, not the seller, a distributor, a repacker or a firm that only milled or micronized it.ICH Q7 11.43 and Q&A 17.4; FDA interim policies (January 2025); 16 CCR 1736.9(d)
Its address and telephoneThe street address of the manufacturing site, and a telephone number in the maker's block.ICH Q7 11.43 and 11.44; WHO model certificate; 16 CCR 1736.9(d)
A reissued certificate points backOn a certificate reissued by a repacker, agent or distributor: the laboratory that tested the lot, the original manufacturer, and a reference to the original batch certificate, with a copy of it attached.ICH Q7 11.43, 11.44 and 17.63; WHO model certificate
Signed for the quality unitA named, authorized signer from quality assurance or quality control, and a date, or an electronic signature traceable to a person.ICH Q7 11.43 and its glossary; WHO model certificate
The testing laboratoryThe laboratory's name and address, results a subcontractor produced marked as such, and any ISO/IEC 17025 accreditation referenced.WHO model certificate; ICH Q7 11.44
The results 6 elements
Each test, its limit and its resultA table of every test performed, its acceptance limit and its result as a figure where the test is numerical, not only "conforms".ICH Q7 11.42; WHO model certificate
The methodA reference to the method or the compendium each test followed.ICH Q7 11.42; WHO model certificate
A conclusionA statement of whether the results are within the specification.WHO model certificate
The monograph, where one existsA statement that the lot meets the current USP or NF monograph, where one exists.21 U.S.C. 353a(b)(1)(A)(i)(I), 353b(a)(2)(B)
Published limits that apply whatever is printedResidual solvents, elemental impurities (FDA says USP <232> and <233> replaced <231>), microbial counts and endotoxin, where they apply.FDA guidance on elemental impurities (2018); ICH Q3C and Q3D
Diethylene and ethylene glycol, for high-risk excipientsFor glycerin, propylene glycol and the other components FDA names, each at not more than 0.10%.FDA guidance on DEG and EG testing (May 2023, Revision 1)
Outside the certificate, and across certificates 3 elements
The maker is registered with FDANot printed on the certificate: found in FDA's establishment registry under the name or FEI printed. Under the interim policies, every later manufacturer too.21 U.S.C. 353a(b)(1)(A)(ii), 353b(a)(2)(C); FDA interim policies (January 2025)
It agrees with every other certificate for the lotThe same values on every document that covers the same lot.ICH Q7 11.40 and 17.20
For a 503B: the facility's own checksAn identity test of its own on each lot, and the supplier's results confirmed at intervals, with the maker's name and location carried into the receiving record.21 CFR 211.84(d)(1) and (d)(2); 21 CFR 211.184(a)

The IPEC excipient guide is paraphrased, not quoted, because its terms forbid reproduction. No USP text is reproduced. Where an element rests on guidance rather than a statute or regulation, the next section says what that means.

Certificate COA-TP-3311 as it was read, 17 numbered lines: Tessaline Supply's quality control header with its address and telephone, the certificate number, product Pyridoxine Hydrochloride USP, lot TP-3311, the manufacturer Halden Fine Chemicals with its address, the dates of manufacture and retest, the supplier, four tests with their specifications and results, the conclusion, the testing laboratory and the approval line
One COA, line by line. Most of the 23 elements are a line on the page, or the absence of one.

Binding, guidance or a model. Each weighs differently.

Not every element binds every pharmacy. The source decides.

The statutes and regulations bind. 21 U.S.C. 353a and 353b, and for an outsourcing facility 21 CFR 211.84 and 211.184. A 503A pharmacy is exempt from the drug CGMP adulteration provision, so Part 211 binds a 503B, not a 503A.

FDA guidance is how FDA reads the word. The interim policies, the draft 503B CGMP guidance and FDA's notices. FDA's guidance says of itself that it contains nonbinding recommendations; it is still the reading an inspector brings.

ICH Q7 is FDA guidance too. FDA publishes it as its guidance for industry on active pharmaceutical ingredients, and its section 17 covers agents, brokers, distributors and repackers, so its section 11.4 on certificates reaches the certificate a supplier hands on.

The WHO model and the IPEC guide are models. Persuasive, widely used, and binding on no one. Page numbering and a certificate number come from them.

A state can add its own. California's sterile rule is the only enumerated list in a regulation. Other states may differ; read your own board's rule.

Ten questions for one COA. An answer or a named gap.

Ask each question of the certificate in your hand. A certificate meets the standard when each has an answer, or the gap is named and asked of the supplier.

  1. The lot

    Does it print the lot number on the container, and name the substance with its salt and form?

  2. The grade

    Does it state a grade fit for a drug, with no restriction on human or drug use?

  3. The maker

    Does it name the original manufacturer, with an address and a telephone, and not only the seller?

  4. The registration

    Is that maker registered with FDA under the name or FEI printed?

  5. The dates

    Does it carry a release date and an expiry or retest date that has not passed?

  6. The pages

    Is every page it numbers in the file?

  7. The signature

    Is it signed and dated by a named person for the quality unit?

  8. The results

    Does each test show its limit, its method and its result as a figure?

  9. The monograph

    Where a USP or NF monograph exists, does it say the lot meets it?

  10. The chain

    If a distributor or repacker issued it, does it point to the original certificate, and is that certificate on file?

Veritura's own COA review follows this list; the methodology names each check it runs and what it does not.

The 11 checks verified on certificate COA-AS-1180 for ascorbic acid, each with the line it was read from and the rule it is held to: names the substance and lot, a grade fit for a drug, names its laboratory and report, may be compounded under 503A, names the monograph it meets, names the original manufacturer and an identity result, among them
The checks this section asks for that one COA passed, each with its line and the requirement behind it.

Free to copy, share and adapt. With credit.

Yes. This standard is published under the Creative Commons Attribution 4.0 International licence (CC BY 4.0).

Anyone may copy, share and adapt it, in any medium, including commercially, provided they credit "Veritura, Valid Certificate of Analysis Standard VTR-COA-20261021", link to this page and the licence, and say if they changed it. The licence text is at creativecommons.org/licenses/by/4.0. The statutes, regulations and FDA documents it quotes are US government works; the ICH and WHO texts keep their own terms.

Version 1, October 21, 2026. A new version follows new FDA guidance or a change in the sources, with the changes listed here.

Documentation evidence only. This standard describes what a certificate carries. It does not say a substance may be compounded, test material, grade a medicine or replace the pharmacist's judgment.

Review your own COA against it.

Drop a COA on the tools page with no account. Nothing you upload is kept.